A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes ...

Older adults with active seizures have worse outcomes when managing a range of daily activities regardless of cognitive status, underscoring the need for greater assessments in this population, ...

At the festival, I am scheduled to read excerpts from my book Crazy for Life, about my psychosis. But I don't have a book, ...

On August 20, a high-powered central inter-departmental committee rejected proposals to include nine medical conditions on the list of disabilities specified un ...

If you've been considering a microcurrent device for your skincare routine, these are the potential benefits and side effects ...

A 14-year-old's near-fatal liver failure from prolonged Ayurvedic treatment underscores growing concerns over herbal medicine ...

People with chronic insomnia may experience faster declines in memory and thinking skills as they age—along with brain changes that can be seen on imaging scans—than people who do not have chronic ...

But a new ultrasound helmet might be able to precisely stimulate areas deep in the brain without the need for surgery, according to findings just published recently in the journal Nature ...

Rapport Therapeutics stock catapulted Monday after its drug reduced seizures in patients with a hard-to-treat form of epilepsy.

Rapport Therapeutics stock jumps 62% in a week as mid-stage study of RAP-219 meets goals in drug-resistant epilepsy patients.

Emma Vukic and Max Bridge, both 38, said their nearly four-year-old daughter Rosie, who is "super lovable and affectionate", ...

"I want her to be here forever, I don't want her to go – especially in the way that she's going to go." Emma and Max, who ...